IHS Chemical Week

Regions :: Western Europe :: Germany

Merck KGaA increases commitment to venture capital fund for start-up biotech firms to €100 million

7:14 AM MDT | May 16, 2013 | Deepti Ramesh

Merck KGaA says it will increase its commitment to its strategic corporate venture capital fund MS Ventures to €100 million ($129 million). MS Ventures is the corporate venture capital fund of Merck Serono, the biopharmaceutical division of Merck. MS Ventures was originally established in March 2009 with a €40 million commitment to invest in emerging biotechnology companies. The new increased commitment secures a long term mandate and will allow MS Ventures to significantly expand its investment activities while still focused on Merck Serono’s...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa